电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SPHK2 抗体 (pSer387)

This 兔 多克隆 antibody specifically detects SPHK2 in WB 和 IHC. It exhibits reactivity toward 人, 小鼠 和 大鼠.
产品编号 ABIN8066720
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for SPHK2 抗体 (pSer387) (ABIN8066720)

抗原

See all SPHK2 抗体
SPHK2 (Sphingosine Kinase 2 (SPHK2))

适用

人, 小鼠, 大鼠

宿主

  • 67
  • 2

克隆类型

  • 69
多克隆

标记

  • 42
  • 4
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This SPHK2 antibody is un-conjugated

应用范围

  • 49
  • 35
  • 32
  • 8
  • 6
  • 5
  • 4
  • 3
  • 3
  • 1
Western Blotting (WB), Immunohistochemistry (IHC)
  • 抗原表位

    • 12
    • 10
    • 9
    • 6
    • 5
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pSer387

    原理

    Phospho-SPHK2 (Ser387) Antibody

    纯化方法

    The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.

    免疫原

    A synthesized peptide derived from human SPHK2 around the phosphorylation site of Ser387.

    亚型

    IgG
  • 应用备注

    WB 1:500-1:2000,IHC 1:50-1:200

    限制

    仅限研究用
  • 状态

    Liquid

    缓冲液

    Rabbit IgG in phosphate buffered saline , pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.

    储存液

    Sodium azide

    注意事项

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    储存条件

    -20 °C

    储存方法

    Store at -20 °C. Stable for 12 months from date of receipt.

    有效期

    12 months
  • 抗原

    SPHK2 (Sphingosine Kinase 2 (SPHK2))

    别名

    SPHK2

    UniProt

    Q9NRA0

    途径

    VEGF Signaling
You are here: